Overtaken by their own success: management is reworking company plans mid-course because real business arrived bigger or
The model's full reasoning — Q2 2021 call → NOWe need answer YES/NO based on transcript. Need analyze if management reveals own working assumptions overtaken by actual activity, bigger/faster/broader than assumed, and already changed something concrete, still catching up. Transcript: Herve says second quarter results impacted by COVID, canceled/postponed all live events except two small shows. Customers enthusiasm. Digital Dealer attendance 65% pre-COVID impacted by supply chain and travel restrictions. But NPS increased, stronger pacing for next iteration. They are set to stage 86 live events in second half. Vaccine confidence. Near-term caution Delta. Planning/staging this quantity of events with shortened lead time presenting challenges, will impact attendance. Goal deliver quality. Focus 2021 not on attendance/revenues but delivering high quality, building toward more normal attendance next year. They see positive signs: Prosper Show staged in Las Vegas 2 weeks ago, essentially in line with pre-COVID 2019, expectations very strong addition next year. Near-term shows constraints from short lead time, pacing 30-70% pre-pandemic. Events in normal time slot pacing better, cities reopened early better, domestic better. Encouraging pacings better further out, 2022 Q1 events pacing much closer, still below pre-COVID. Expect substantial recovery. Business model negative working capital, deposits, strong free cash flow. Strategic imperatives: customer centricity, 365 engagements, portfolio optimization. Data integration completed. PlumRiver ElasticSuite progress, double new client wins vs last year. Sue Bryce acquisition, SIAL America launch. David: Q2 revenues $15M vs $7M year ago. Organic $11.6M vs $6.3M. Adjusted EBITDA negative $13.6M vs positive $33.2M due to lower insurance proceeds. Event cancellation insurance claims. Free cash flow inflow $23.8M vs outflow $32.6M. Deferred revenue increased from $48.6M at year-end to $119.2M at June 30. CapEx low. Cash $302.8M. Credit facility extended. Net debt $219.6M. They maintain $200M event cancellation insurance for 2021. They are vigilant to mitigate expenses.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| DGX | Quest Diagnostics Incorporated | Q2 2021 | 2021-07-22 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
EMR · Q3 2021 → YESThe question is whether management reveals that the company's own working assumptions have been overtaken by actual events, they've already changed something concrete, and they're still catching up. ...YES The transcript shows management confirming that actual operating activity (sales/orders growth, demand recovery, project wins) has outrun their own prior expectations and plans for the quarter and year. They explicitly note sales/orders "ahead of our expectations," "exceeding our management expectations," and a "V-shaped demand recovery" plus 26% trailing orders that accelerated beyond what was assumed. In response, they have already taken concrete actions: ramping up capacity at plants in the U.S.
MNKD · Q4 2023 → YESThe question is whether management reveals that the company's own working assumptions have been overtaken by actual events, they've already changed something concrete, and they're still catching up. ...YES The transcript shows management confirming that Tyvaso DPI demand and production have run ahead of their own earlier assumptions: the launch was “under-forecast,” actual patient uptake and volumes exceeded what they had planned, and they had to “work incredibly hard” and add capacity (high-speed fill line) to keep up 100 % of demand. They have already acted by completing the new line qualification, starting PPQ runs, and ramping production “much higher” volumes in Q1/Q2.
AOSL · Q2 2018 → YESThe question is whether management reveals that the company's own working assumptions have been overtaken by actual events, they've already changed something concrete, and they're still catching up. ...YES The transcript shows management describing a clear upward surprise in demand for new products that has already outrun their existing capacity plans ("demand for our new products has increased in the last year or so... capacity constraints have caused us to forgo potential revenue... tens of millions of dollars"), with the Chongqing JV built specifically to address it.